B
BioAge Labs, Inc. (BIOA)
NMS – Real Time Price. Currency in USD
16.15
-0.10 (-0.62%)
At close: Mar 27, 2026, 4:00 PM EDT
16.15
0.00 (0.00%)
After-hours: Mar 27, 2026, 4:10 PM EDT
Get all premium features to the best stock analysis tool
NMS – Real Time Price. Currency in USD
16.15
-0.10 (-0.62%)
At close: Mar 27, 2026, 4:00 PM EDT
16.15
0.00 (0.00%)
After-hours: Mar 27, 2026, 4:10 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 11.87 | 2.52 | 10 | |
| Quick ratio | 11.87 | 1.78 | 10 | |
| Debt to Equity | 0.03 | -0.80 | 9.0 | |
| Debt to Assets | 0.02 | 0.73 | 9.0 | |
| Interest coverage | -155.30 | -13.90 | 1.0 | |
| Weighted average score | 7.8 | |||
| METRIC | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | 6M |
| Gross Profit | -129K | -162K | -167K | 6M |
| Operating Income | -40M | -48M | -78M | -90M |
| Net Income | -40M | -64M | -71M | -76M |
| EBITDA | -40M | -48M | -78M | -90M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 26.17 | 5.5 |
| Next quarter | -50.38 | -80.8 | 1.0 |
| Current year | N/A | 65.81 | 5.5 |
| Next year | 898.9 | -21.94 | 5.5 |
| Weighted average score | 4.4 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -14.83 | 6.46 | 6.67 | 20.18 | 5.3 |
| Y/Y | 999 | 13.82 | 91.64 | -5.44 | 7.3 |
| 3y average | N/A | N/A | N/A | N/A | 1.0 |
| 5y average | N/A | N/A | N/A | N/A | 1.0 |
| Weighted average score | 3.7 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Company's cash reserves $215.6M significantly exceed its total debt $7.1M, ensuring strong financial flexibility
Total current assets $290.8M exceed Total current liabilities $24.5M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (-0.8), showcasing prudent financial management
Interest coverage ratio (-155.3x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$16.1M limits the company's ability to reinvest or pay down debt